Trophic interactions between pulmonary epithelial and mesenchymal cell types, known as the epithelialmesenchymal trophic unit (EMTU), are crucial in lung development and lung disease. Transforming growth factor (TGF)-␤ is a key factor in mediating these interactions, but it is expressed in a latent form that requires activation to be functional. 
The lung develops from tightly orchestrated interactions between opposing layers of epithelial and mesenchymal cells separated by a basement membrane, the components of the epithelial-mesenchymal trophic unit (EMTU). 1 During development these reciprocal interactions are driven by paracrine factors that determine the differentiation state of airway epithelial cells and fibroblasts. 2, 3 In the adult, reactivation of the EMTU has been proposed to occur in response to injury contributing either to the maintenance of homeostasis or to lung pathology, depending on the nature and duration of the insult. 1, 4, 5 The multifunctional cytokine transforming growth factor (TGF)-␤ has been widely implicated as a master regulatory cytokine, acting as both an autocrine and paracrine factor in lung development and in the regulation of homeostasis of the EMTU. 5, 6 Thus, mice genetically engineered to be deficient in TGF-␤1 develop pulmonary inflammation, airway epithelial hyperplasia, and dysplasia. [7] [8] [9] In addition, mice that are haploinsufficient in TGF-␤1 are more susceptible to chemically induced pulmonary carcinoma, whereas overexpression of TGF-␤ in the mouse lung results in pulmonary fibrosis. 10, 11 Mice deficient in TGF-␤3 show defective airway branching. 6 These results highlight the importance of TGF-␤ in the homeostatic regulation of pulmonary immunity, epithelial growth, and extracellular matrix deposition as well as in lung development.
TGF-␤ is ubiquitously expressed in multiple cell types in the lung in three isoforms (TGF-␤1 to TGF-␤3), but almost entirely in an inactive (latent) form. 12 Latent-TGF-␤ is further covalently linked to the extracellular matrix by binding to latent TGF-␤-binding proteins. 13 Therefore, the activation of TGF-␤ from these latent stores is a major point of regulation of TGF-␤ function. TGF-␤ is activated by diverse mechanisms in the lung, ultimately involving either proteolysis or conformational alteration of the latency-associated peptide (LAP) of TGF-␤. 12 Recently, it has become evident that certain integrins are able to mediate activation of TGF-␤ and may be essential components of the TGF-␤ activation apparatus. 14, 15 Thus, integrins have the potential to sequester latent TGF-␤ to the cell surface, where activation can be tightly coupled to cellular responses to environmental stress to maintain homeostasis.
The LAP of TGF-␤1 and -3 contains the RGD tri-peptide motif, which binds to a subset of integrins. 14 -18 Of the six different integrins that bind to LAP-␤1, only two appear to be able to activate TGF-␤, ␣ v ␤ 6 , and ␣ v ␤ 8 efficiently.
14, 15 The ␣ v ␤ 6 integrin mediates activation of TGF-␤ through a mechanism involving the conformational alteration of TGF-␤; the ␣ v ␤ 8 integrin mediates activation of TGF-␤ through the transmembrane matrix-metalloprotease-1 (MT1-MMP)-dependent cleavage of LAP. 14, 15 These different mechanisms of integrin-mediated activation may have evolved to serve cell-type-specific roles in particular physiological settings.
In the airway and alveolar epithelium, the integrin ␣ v ␤ 6 is normally expressed at low levels but can be induced by inflammatory stimuli; the integrin ␣ v ␤ 8 is normally expressed at high levels by normal airway epithelium. 11, 19 The implications of these patterns of integrin expression are that the ␣ v ␤ 6 -dependent conformational mechanism of TGF-␤ activation would be biased toward TGF-␤ activation at injured sites after the local induction of ␣ v ␤ 6 expression; the ␣ v ␤ 8 -dependent mechanism of TGF-␤ activation involving the metalloprotease-dependent liberation of active TGF-␤ would support homeostatic paracrine interactions between normal cells.
We have recently developed a system based on the use of intact human bronchial tissue to evaluate the role of integrin-mediated activation of TGF-␤ in the wounded adult human airway. Thus, we found that the integrin ␣ v ␤ 8 is expressed at high levels in fragments of intact bronchial tissues and that it mediates activation of TGF-␤, ultimately inhibiting epithelial cell growth. 20 These findings suggest a possible role for TGF-␤ during the reactivation of the EMTU in the injured adult airway. However, the EMTU has only been rigorously experimentally defined in nonhuman lung systems, which have significant differences in anatomy and cell-type distribution from human lungs. 3, 21 For instance, rodent airways are relatively lacking in basal cells, the cell type in which ␣ v ␤ 8 and ␣ v ␤ 6 are expressed in human airway. 11, 19 Therefore, we sought to develop a model of the human EMTU to define the role that integrin-mediated activation of TGF-␤ plays in epithelial-mesenchymal interactions because these same interactions are likely to contribute to airway disease in the adult.
Here, we describe the individual roles that fetal tracheal epithelial cells and fetal tracheal fibroblasts play in integrin-mediated activation of TGF-␤ and then demonstrate the cell-type-dependent role of TGF-␤ activation in autocrine and paracrine interactions within the human EMTU. Surprisingly, we found that despite expressing robust levels of ␣ v ␤ 8 , fetal tracheal epithelial cells fail to efficiently activate TGF-␤ unless stimulated with phorbol esters, an effect most likely attributable to the increased activity of MT1-MMP. In contrast, we find that fetal tracheal fibroblasts express relatively low levels of ␣ v ␤ 8 but efficiently support ␣ v ␤ 8 -dependent activation of TGF-␤. Furthermore, autocrine activation of TGF-␤ by fetal tracheal fibroblasts leads to the suppression of transcription and secretion of hepatocyte growth factor (HGF), a potent airway epithelial cell mitogen. This suppression of HGF is sufficient to negatively impact both phosphorylation of the HGF receptor c-Met, expressed by fetal tracheal epithelial cells, as well as proliferation of fetal tracheal epithelial cells. Taken together, our results suggest that integrins, in particular the integrin ␣ v ␤ 8 , are central regulators of homeostatic interactions within the human pulmonary EMTU.
Materials and Methods

Cell Culture, Antibodies, and Reagents
Fetal tracheas were obtained at the time of elective termination of intrauterine pregnancy (18 to 22 weeks gestation) from otherwise healthy females. Informed consent was obtained from all participants as part of an approved ongoing research protocol by the University of California, San Francisco, Committee on Human Research. Tracheal fragments were microdissected into 0.2-to 0.5-mm fragments and cultured in an individual well of an agarcoated 96-well plate using the liquid overlay culture technique as described. 20 Fetal tracheal epithelial cells were isolated as previously described. 22 Freshly isolated fetal tracheal epithelial cells were plated onto rat-tail collagen type I (10 g/ml)-coated dishes and incubated overnight, and then the medium was changed to bronchial epithelial growth medium (Clonetics, San Diego, CA). Fetal tracheal fibroblasts were cultured from the tracheal tissues remaining after epithelial cell isolation by the explant technique. 22 Briefly, fibroblasts outgrown from tracheal fragments were cultured in fibroblast growth media (Dulbecco's modified Eagle's medium with 10% fetal calf serum and penicillin-streptomycin; UCSF Cell Culture Facility). Confluent cells were passaged by trypsin treatment (0.025%; UCSF Cell Culture Facility) and used for the experiments at the initial passage (P1). Wild-type SW480 (American Type Culture Collection, Rockville, MD) and SW480 cells stably transduced with integrin ␤ 8 were prepared and passaged as described. 19 All cells were incubated at 37°C in a humidified incubator in 7.5% CO 2 . Cultures were characterized immunohistochemically using anti-prolyl-4-hydroxylase (DAKO, Carpinteria, CA), anti-vimentin (Sigma, St. Louis, MO), and anti-cytokeratin antibodies (Lu-5; BioCare Medical, Concord, CA). Fetal tracheal epithelial cells showed Ͼ95% positive staining with anti-cytokeratin and Ͻ5% positive staining with the anti-vimentin antibody. Fetal tracheal fibroblasts demonstrated Ͼ95% positive staining with anti-prolyl-4-hydroxylase and anti-vimentin antibodies and Ͻ5% positive staining with the anti-cytokeratin antibody (data not shown).
Additional antibodies used were mouse anti-␤ 8 25 (gift of Dr. Matsuzaki, Kansai Medical University, Osaka, Japan); anti-phosphorylated c-Met and anti-c-Met (Cell Signaling Technology, Beverly, MA); and anti-smooth muscle actin (SMA, Sigma). Recombinant active TGF-␤1 and HGF (R&D Systems), gelatin (Sigma), pro-MMP-2 (Chemicon), and the panmetalloprotease inhibitor GM6001 (Ryss Lab, Union City, CA) were purchased. Rat-tail collagen was isolated as previously described. 26 The GST-␤ 8 cytoplasmic domain fusion protein was prepared as previously described. 27 
Immunocytochemistry, Immunohistochemistry, and Flow Cytometry
Immunohistochemistry was performed as previously described with minor modification. 19 Briefly, the fetal tracheal tissue was formalin-fixed and paraffin-embedded or flash-frozen in embedding medium (VWR, Westchester, PA). The anti-␤ 8 primary antibody was applied after preabsorption onto frozen sections of fetal liver. Flow cytometry was performed as previously described. 19 
RNA Isolation and Reverse TranscriptasePolymerase Chain Reaction (RT-PCR)
RNA isolation, reverse transcription, and polymerase chain reaction were performed as previously described. 15 The primers used were ␤ 8 integrin sense primer, 5Ј-CATCT-GAAAAACAACGTCTACG-3Ј; ␤ 8 integrin anti-sense primer, 5Ј-ATCTGGACAGATGGCGGTAAT-3Ј; HGF sense primer 5Ј-CAGAGGGACAAAGGAAAAGAA-3Ј, HGF anti-sense primer 5Ј-GCAAGTGAATGGAAGTCCTTTA-3Ј; ␤-actin sense primer 5Ј-TGACGGGGTCACCCACACTGTGCC-3Ј, ␤-actin anti-sense primer 5Ј-CTAGAAGCATTTGCGGTG-GACGATGGAGGG-3Ј. These primer sets yielded PCR products of 306, 167, and 662 bp for ␤ 8 integrin, HGF, 28 and ␤-actin, respectively.
Immunoprecipitation Analysis, Western Blotting, and Zymography
Confluent dishes of cells were surface-labeled with 0.1 mg/ml NHS-LC-biotin (Pierce Corp., Rockford, IL) and lysed in Tris-buffered saline with 1% Triton X-100, 1 mmol/L phenylmethyl sulfonyl fluoride, and protease inhibitor cocktail (Calbiochem, San Diego, CA). Immunoprecipitations and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were performed as previously described. 27 After transfer to polyvinylidene difluoride membrane (Immobilon-P; Amersham, Arlington Heights, IL), biotinylated proteins were detected by horseradish peroxidase-streptavidin conjugate (Amersham) followed by enhanced chemiluminescence (Amersham). Western blotting was performed as described with minor modification. 19 Briefly, fibroblast-conditioned medium was used to treat fetal tracheal epithelial cells for 1 hour, followed by lysis in Tris-buffered saline with 1% Triton X-100, 1 mmol/L phenylmethyl sulfonyl fluoride, 5 mmol/L ethylenediaminetetraacetic acid, 1 mmol/L sodium orthovanadate (Sigma), and protease inhibitor cocktail (Calbiochem). Zymography was performed as previously described. 15 
TGF-␤ Bioassay
The TGF-␤ bioassays were performed as previously described. 15, 20 TMLC cells (the generous gift of John Munger and Daniel Rifkin, New York University, New York, NY) 29 were cultured with fetal tracheal fragments, epithelial cells, or fibroblasts pretreated (3 hours) or not with 1 or 10 nmol/L phorbol 12-myristate-13-acetate (PMA, Sigma), anti-pan-TGF-␤-blocking antibody, or isoform-specific TGF-␤ antibodies, anti-␤ 8 -specific antibody (clone 37E1), or pan-metalloprotease inhibitor GM6001 (Ryss Lab, Inc., Union City, CA). TGF-␤ standard curves were generated with a 1:2 dilution series of recombinant TGF-␤ added to the TMLC bioassay.
HGF Enzyme-Linked Immunosorbent Assay
Fetal tracheal fibroblasts were grown to confluence in 12-well tissue culture plates, washed two times with PBS, and then incubated in serum-free Dulbecco's modified Eagle's medium in the presence or absence of anti-pan-TGF-␤-blocking antibody or anti-␤ 8 -specific antibody with or without recombinant active TGF-␤1 for 24 hours. HGF was measured in conditioned media with an HGF Quantikine ELISA kit (R&D Systems).
Co-Culture Model of the EMTU
Fetal tracheal fibroblasts (10 ϫ 10 4 ) were cultured for 12 to 16 hours on culture inserts (1 m pore size; Fisher Scientific, Pittsburgh, PA) in a 24-well plate in fibroblast growth media. Fetal tracheal epithelial cells (5 ϫ 10 4 ) were cultured for 12 to 16 hours on rat-tail collagen (10 g/ml coating concentration)-coated wells of a 12-well tissue culture plate (Fisher Scientific, Pittsburg, PA) in 1 ml of bronchial epithelial growth medium (Clonetics). The culture inserts containing the fetal tracheal fibroblasts were placed into wells containing fetal tracheal epithelial cells, and the media in the upper and lower chambers was changed to Dulbecco's modified Eagle's medium with 0.1% fetal calf serum and penicillin and streptomycin in the presence or absence of neutralizing anti-pan-TGF-␤, anti-␤ 8 , anti-HGF, anti-␤ 8 plus anti-TGF-␤, or a control nonfunction-blocking anti-␣ v integrin subunit antibody (8b8 15 ). Cell proliferation was determined by cell counting, as described. 19 Cell adhesion assays were performed as described. 27 
Collagen Gel Contraction Assay
Collagen gels were prepared as previously described with slight modification. 30 A collagen solution was pre-pared from 1.5 ml of Vitrogen (Cohesion, Palo Alto, CA), 0.3 ml of 10ϫ ␣-minimal essential medium, 0.3 ml of 0.26 mol/L NaHCO 3 , 0.3 ml of fetal calf serum, 0.12 ml of 0.1 mol/L NaOH, and 0.5 ml of fibroblast suspension (6 ϫ 10 5 /ml of gel) in the presence or absence of recombinant active TGF-␤1 or neutralizing antibodies against TGF-␤ or ␤ 8 . Five hundred l of the gel solution was then cast in each well of a 24-well plate, and the plates were incubated at 37°C to induce gelation. A spatula was used to loosen the edges of formed gel from the well, and the maximal gel diameter was measured at 0 and 72 hours.
Statistics
Student's t-test was used for comparison of two data sets. Tukey's or Dunn's test were used for parametric and nonparametric data, respectively, to find where the difference lay. Significance was defined as P Ͻ 0.05. Statistical software was Prism version 3cx (GraphPad Software, Inc., San Diego, CA).
Results
Integrin ␣ v ␤ 8 Is Expressed by Fetal Tracheal Epithelial Cells and Fibroblasts
We used immunohistochemistry of fetal trachea to determine the relative expression levels and cell-type distribution of the two integrins, ␣ v ␤ 8 and ␣ v ␤ 6 , thought to account for the majority of TGF-␤ activation in the adult airway. 20 Strong ␤ 8 immunoreactivity of the fetal tracheal epithelial cells and weak staining of the subepithelial mesenchymal cells, which are a heterogeneous population of fibroblasts and myofibroblasts, was demonstrated ( Figure 1 , A and B). The staining was specific because no staining was seen in control sections preabsorbed with the immunogenic antigen ( Figure 1C ). The integrin ␤ 6 was expressed at very low levels in the fetal tracheal epithelium, concentrated in the necks of glands, and in small clusters of cells; no staining was found in cells of the mesenchymal layer ( Figure 1D ). The intracellular TGF-␤ signaling mediator SMAD-2 was activated in the majority of fetal tracheal epithelial and mesenchymal cells because an antibody recognizing phosphorylated SMAD-2 demonstrated nuclear localization in these cell types ( Figure 1E ).
Fetal Tracheal Epithelial Cells and Fibroblasts Express the Integrin
To confirm our immunohistochemical data, we determined the integrin expression profiles of fetal tracheal fibroblasts and fetal tracheal epithelial cells. A robust amplification product for the ␤ 8 integrin subunit transcript was easily detected from fetal tracheal fibroblasts ( Figure  2A We next performed flow cytometry of cultured fetal tracheal epithelial cells ( Figure 2B ) and fetal tracheal fibroblasts ( Figure 2C ) to confirm the surface expression of ␣ v ␤ 8 in fetal tracheal fibroblasts. The integrin ␣ v ␤ 8 was expressed at similar levels as the ␣ v ␤ 6 integrin by passage 1 fetal tracheal epithelial cells ( Figure 2B ). The integrin ␣ v ␤ 8 was expressed at easily detectable levels by fetal tracheal fibroblasts, albeit at 10-fold lower levels than in fetal tracheal epithelial cells ( Figure 2C ). The integrin ␣ v ␤ 6 was not expressed by fetal tracheal fibroblasts ( Figure 2C ).
To determine whether the integrin ␣ v ␤ 8 was expressed on the fetal tracheal epithelial cells and fibroblasts as a proper integrin heterodimer, we performed immunoprecipitation of surface-labeled cell lysates using integrin subunit-specific antibodies (Figure 2, D and E) . The integrin ␣ v ␤ 8 was easily detected as an integrin heterodimer on fetal tracheal epithelial cells ( Figure 2D ) and fibroblasts ( Figure 2E ) because it could be immunoprecipitated by two separate integrin ␤ 8 antibodies, both of which immunoprecipitated two bands that co-migrated with the ␣ and ␤ bands from an ␣ v immunoprecipitation and migrated at the expected molecular weights previ- 408 Araya et al AJP August 2006, Vol. 169, No. 2 ously reported for the ␣ v and ␤ 8 subunits. 27 Consistent with flow cytometry data, fetal tracheal epithelial cells expressed both the ␣ v ␤ 6 and ␣ v ␤ 8 integrins ( Figure 2D ) whereas fetal tracheal fibroblasts expressed ␣ v ␤ 8 and no ␣ v ␤ 6 ( Figure 2E ). Taken together these results demonstrate that ␣ v ␤ 8 is expressed on the cell surface of cultured fetal tracheal fibroblasts at lower levels than on fetal tracheal epithelial cells, as predicted by the relative intensities of ␤ 8 staining seen on fetal tracheal epithelial cells and fibroblasts using immunohistochemistry ( Figure  1A ).
The ␣ v ␤ 6 and ␣ v ␤ 8 Integrins Mediate the Majority of TGF-␤ Activation in Intact Fragments of the Fetal Trachea
We next determined the total TGF-␤ activation and integrin-dependent TGF-␤ activation using cultured fetal tracheal fragments ( Figure 3A) . Most TGF-␤ produced by the fragments was latent because only 9.9 Ϯ 1.6% of the total TGF-␤ was active, as determined by comparing heat-activated versus nonheat-activated conditioned media from fetal tracheal fragments. The active TGF-␤ produced by fetal tracheal fragments was almost completely dependent on the ␣ v ␤ 8 and ␣ v ␤ 6 integrins, with the ␣ v ␤ 8 integrin responsible for a greater fraction of TGF-␤ activation than ␣ v ␤ 6 ( Figure 3A) . These data mirror results obtained previously using human adult bronchial fragments. 20 
The ␣ v ␤ 8 Integrin Mediates TGF-␤3 Activation in Fetal Tracheal Fibroblasts through a Metalloprotease-Dependent Mechanism
To elucidate which cellular compartments of the fetal trachea were responsible for the integrin-mediated TGF-␤ activation, we used cultures of isolated fetal tracheal epithelial cells or fetal tracheal fibroblasts. At the first passage, fetal tracheal epithelial cells expressed similar levels of ␣ v ␤ 6 and ␣ v ␤ 8 integrins ( Figure 2B ). However, they activated TGF-␤ mainly via the ␣ v ␤ 6 inte- grin ( Figure 3B ). Simultaneous use of both ␤ 6 -and ␤ 8 -specific antibodies showed an additive blocking effect on TGF-␤ activation, blocking TGF-␤ activation almost as well as a pan-TGF-␤ antibody ( Figure 3B ). Isolated fetal tracheal fibroblasts activated TGF-␤ in the TMLC assay, and this activation was almost entirely ␣ v ␤ 8 -dependent because a ␤ 8 -specific neutralizing antibody decreased TGF-␤ activation almost as well as pan-TGF-␤ neutralizing antibody. A control antibody to ␣ v ␤ 6 , which is not expressed by fetal tracheal fibroblasts, had no effect ( Figure 3C ). The amount of fibroblastic ␣ v ␤ 8 -dependent TGF-␤ activation in this assay was ϳ20 pg/ml (data not shown).
Although ␣ v ␤ 6 and ␣ v ␤ 8 appear to account for ϳ90% of the TGF-␤ activated by fetal tracheal epithelial cells, and ␣ v ␤ 8 accounts for ϳ80% of the TGF-␤ activated by fetal tracheal fibroblasts, we cannot exclude a small contribution from other TGF-␤ activation mechanisms such as thrombospondin, plasmin, or the integrins ␣ v ␤ 3 and ␣ v ␤ 5 , which have recently been implicated in TGF-␤ activation in scleroderma fibroblasts. 7, 12, 31, 32 However, neutralizing antibodies to ␣ v ␤ 3 or ␣ v ␤ 5 had no effect on fetal tracheal epithelial cell or fibroblast TGF-␤ activation (data not shown). Thus, despite expressing the ␣ v ␤ 3 integrin at similar levels and the ␣ v ␤ 5 integrin at 10-fold higher levels compared to ␣ v ␤ 8 , fetal tracheal fibroblasts failed to show any ␣ v ␤ 3 -or ␣ v ␤ 5 -dependent activation of TGF-␤. This result is consistent with previous studies failing to show ␣ v ␤ 3 -or ␣ v ␤ 5 -dependent activation of TGF-␤, despite the integrin ␣ v ␤ 3 being highly expressed by many tumor cell lines and primary cells in culture and ␣ v ␤ 5 being nearly ubiquitously expressed in culture. 14, 15, 18, 20, 33 This suggests that ␣ v ␤ 3 -and ␣ v ␤ 5 -dependent activation of TGF-␤ is likely confined to specific cell types, such as scleroderma fibroblasts, but does not play a major role in the cell types used in this study.
To determine the TGF-␤ isoform(s) activated by ␣ v ␤ 8 in fetal tracheal fibroblasts, we used TGF-␤1 and -␤3 isoform-specific neutralizing antibodies (the LAP of TGF-␤2 does not contain an RGD site, which is required for integrin-mediated activation of TGF-␤ 14, 15 ). TGF-␤3 accounted for the majority of ␣ v ␤ 8 -mediated activation of TGF-␤ because neutralizing antibodies against TGF-␤3 blocked fibroblastic activation of TGF-␤ almost as well as anti-␤ 8 ( Figure 3D ). These findings are consistent with our previous results using adult human bronchial fragments in which we found that the integrin ␤ 8 subunit and TGF-␤3 have overlapping patterns of distribution and the transcript for the TGF-␤3 isoform was expressed in 200-fold excess to the TGF-␤1 isoform. 20 We have recently reported that ␣ v ␤ 8 integrin-mediated TGF-␤ activation is dependent on the presence of the membrane type 1 matrix metalloprotease (MT1-MMP), which facilitates the release of active TGF-␤ into the extracellular space. 15 Indeed, the metalloprotease inhibitor GM6001 significantly blocked fetal tracheal fibroblast ␣ v ␤ 8 integrin-mediated TGF-␤ activation almost as efficiently as an anti-␤ 8 -specific antibody ( Figure 3E ), confirming the involvement of a metalloprotease in TGF-␤ activation by fetal tracheal fibroblasts.
Fetal Tracheal Epithelial Cells Regulate ␣ v ␤ 8 -Mediated Activation of TGF-␤ through Induction of MT1-MMP Activity
Fetal tracheal epithelial cells do not efficiently support ␣ v ␤ 8 -mediated activation of TGF-␤ despite expressing 10-fold higher levels of ␣ v ␤ 8 than fetal tracheal fibroblasts ( Figure 2C ), suggesting that MT1-MMP activity might be reduced in fetal tracheal epithelial cells. MT1-MMP activity has been shown to be dependent on levels of both surface expression and activation state. 15, 34 Indeed, low levels of cell surface MT1-MMP were found in fetal tracheal epithelial cells, whereas high levels of cell surface MT1-MMP were found in fetal tracheal fibroblasts and HT1080 cells, correlating with the relative ability of these cell types to support ␣ v ␤ 8 -dependent TGF-␤ activation 15 ( Figure 4A ). PMA has been shown to increase both the expression and activation state of MT1-MMP. 34, 35 PMA treatment markedly increased both the surface expression and activity of MT1-MMP, as determined by immunoprecipitation of surface labeled cells ( Figure 4B ) and cleavage of the MT1-MMP substrate pro-MMP2 ( Figure  4C ) by fetal tracheal epithelial cells. These changes were similar to those in a control cell line, HT1080, known to increase its surface expression and activity of MT1-MMP in response to PMA 35 ( Figure 4 , B and C). PMA treatment markedly increased the total and ␣ v ␤ 8 -dependent activation of TGF-␤ by fetal tracheal epithelial cells ( Figure 4D ). Finally, this increase in ␣ v ␤ 8 -mediated activation of TGF-␤ was metalloprotease-dependent because GM6001 could block TGF-␤ activation to a similar extent as the neutralizing ␤ 8 antibody ( Figure 4D ).
Autocrine ␣ v ␤ 8 -Mediated TGF-␤ Activation Regulates HGF Secretion by Fetal Tracheal Fibroblasts, Which Is Sufficient to Impact Fetal Tracheal Epithelial Proliferation
HGF is a mesenchymal-derived growth factor that is a potent lung epithelial mitogen and morphogen. 36, 37 The release of HGF from fibroblasts is regulated by autocrine TGF-␤ signaling. 38 However, little is known of the source of active TGF-␤ produced by fibroblasts. ␣ v ␤ 8 -Mediated activation of TGF-␤ regulated the autocrine secretion of HGF by fetal tracheal fibroblasts because the amount of HGF secreted into conditioned medium was significantly increased by a pan-TGF-␤-neutralizing antibody or a ␤ 8 -neutralizing antibody ( Figure 5A ). However, the ␣ v ␤ 8 -dependent autocrine suppression of HGF was incomplete because high concentrations (2 ng) of exogenous TGF-␤ could almost completely suppress HGF secretion ( Figure 5A ). The effect of the ␣ v ␤ 8 antibody was specific to TGF-␤ activation because 20 pg/ml of recombinant TGF-␤, the amount of TGF-␤ activated by fibroblastic ␣ v ␤ 8 in this system, was able to almost completely block the ␣ v ␤ 8 antibody-mediated increase in fibroblastic HGF secretion ( Figure 5B ). The autocrine ␣ v ␤ 8 -dependent suppression of HGF was attributable to the transcriptional suppression of HGF, as demonstrated by an increase in the HGF amplification product after treatment with neutralizing ␤ 8 or TGF-␤ antibodies ( Figure 5C ). The amount of HGF suppressed by ␣ v ␤ 8 -mediated activation of TGF-␤ was physiologically significant because the phosphorylation of the HGF receptor, c-Met, expressed by fetal tracheal epithelial cells increased after exposure to the conditioned medium from fetal tracheal fibroblasts treated with neutralizing anti-␤ 8 or anti-TGF-␤ ( Figure 5D , top). These ␣ v ␤ 8 -dependent changes in c-Met phosphorylation status were attributable to increased phosphorylation of c-Met and not because of an overall increase in total c-Met because treatment of fetal tracheal fibroblasts by anti-␤ 8 or anti-TGF-␤ did not change total protein levels of c-Met (Figure 5D, bottom) . Conditioned media from fetal tracheal fibroblasts treated with exogenous active TGF-␤ did not efficiently induce c-Met phosphorylation by fetal tracheal epithelial cells (Figure 5D ), consistent with a TGF-␤-dependent reduction of HGF secretion ( Figure 5, A-C) .
In the EMTU, the airway epithelial cells are physically separated from fibroblasts by a porous basement membrane. 4 To test the physiological significance of ␣ v ␤ 8 -mediated autocrine TGF-␤ in fetal tracheal fibroblastic regulation of HGF secretion, we devised a co-culture model mimicking the in vivo situation by separating fetal tracheal epithelial cells from fetal tracheal fibroblasts by a porous transwell filter. We found that fetal tracheal epithelial proliferation was not significantly increased by co- hatched bar) , or a combination of neutralizing antibodies to ␤ 8 and HGF (cross-hatched bar). As controls, the effects of the same antibodies on fetal tracheal epithelial proliferation in monoculture are shown on the left. E-F: The effect of the blocking anti-␤ 8 antibodies on fetal tracheal cell proliferation are specific to the fibroblasts in the co-culture model because the antibodies do not significantly effect proliferation (E) and do not effect adhesion (F) of the fetal tracheal epithelial cells to the coating substrate of the co-culture assay (collagen I, Col I) or to a control substrate (fibronectin, FN). *P Ͻ 0.05, **P Ͻ 0.001. Shown is SE.
culture with fetal tracheal fibroblasts under control conditions (control antibody or no primary antibody), relative to fetal tracheal epithelial cells cultured alone ( Figure 5E ; monoculture versus co-culture, filled bar and vertical hatched bars). In contrast, fetal tracheal epithelial proliferation markedly increased in co-cultures treated with neutralizing antibodies to TGF-␤ or anti-␤ 8 ( Figure 5E ; open bar and horizontal hatched bar). The increase in fetal tracheal epithelial proliferation was mostly attributable to HGF because a neutralizing antibody to HGF blocked the majority of increase in fetal tracheal epithelial proliferation induced in co-cultures by anti-␣ v ␤ 8 ( Figure  5E , crosshatched bar). The effect of the anti-␤ 8 antibody on fetal tracheal epithelial cell proliferation was not because of an effect of the anti-␤ 8 , TGF-␤, or HGF antibody directly on fetal tracheal epithelial cells because the antibodies had an insignificant effect on proliferation ( Figure  5E ; monoculture, open, horizontal hatchmark, and crosshatched bars), or adhesion to the coating substrate collagen I or to fibronectin, a major pericellular matrix protein ( Figure 5F ). The source of the HGF in this system was solely from fetal tracheal fibroblasts because HGF was not detected in the fetal tracheal epithelial conditioned media (data not shown). These experiments demonstrate that autocrine ␣ v ␤ 8 integrin-mediated activation of TGF-␤ by fetal tracheal fibroblasts regulates the physiologically relevant secretion of HGF.
Autocrine ␣ v ␤ 8 -Mediated Activation of TGF-␤ by Fetal Tracheal Fibroblasts Regulates Fibroblast Differentiation
TGF-␤ plays a well-established role in controlling the differentiation of fibroblasts into myofibroblasts, regulating the expression of crucial components of the contractile apparatus such as SMA. 39 Fetal tracheal fibroblasts display a myofibroblastic contractile phenotype as determined by expression of SMA and contraction of collagen gels ( Figure 6, A and B) . ␣ v ␤ 8 -Dependent autocrine activation of TGF-␤ by fetal tracheal fibroblasts contributes to SMA expression and the contractile phenotype because neutralizing antibodies to ␣ v ␤ 8 or TGF-␤ produce a modest but significant reduction in SMA expression and the contraction of collagen gels ( Figure 6, A and B ). These results demonstrate that ␣ v ␤ 8 -dependent autocrine activation of TGF-␤ by fetal tracheal fibroblasts contributes to the myofibroblast phenotype.
Discussion
The findings of this study elucidate the complex regulation of TGF-␤ activation and role of TGF-␤ in autocrine and paracrine interactions within the human EMTU. The major findings are as follow: the integrins ␣ v ␤ 6 and ␣ v ␤ 8 account for the majority of TGF-␤ activated within the human EMTU as demonstrated using fragments of intact fetal tracheal tissue; isolated fetal tracheal epithelial cells constitutively activate TGF-␤ mainly through an ␣ v ␤ 6 -dependent mechanism whereas fetal tracheal epithelial cell ␣ v ␤ 8 -dependent activation of TGF-␤ is regulated by the induction of metalloprotease activity; in contrast, isolated fetal tracheal fibroblasts constitutively activate TGF-␤ mainly through an ␣ v ␤ 8 -dependent mechanism; and integrin ␣ v ␤ 8 -mediated autocrine activation of TGF-␤ suppresses the paracrine secretion of HGF by fetal tracheal fibroblasts, which is sufficient to negatively regulate fetal tracheal epithelial proliferation in a co-culture model of the EMTU.
We developed a unique system based on human intact fragments of fetal tracheal tissues and isolated fetal cells to demonstrate the central role that integrin-mediated TGF-␤ activation plays in maintaining homeostasis in the EMTU. Such an ex vivo system provides a reasonably close approximation to in vivo events and closely models the complex interactions in play during development of the human fetal airway. We have previously developed a similar system based on the use of intact adult human bronchial tissues to show that ␣ v ␤ 8 -mediated activation of TGF-␤ regulates adult airway epithelial proliferation. 20 In this previous study, we did not determine the cellular 412 Araya et al AJP August 2006, Vol. 169, No. 2 source of the active TGF-␤ but found that ␤ 8 was highly expressed in the airway epithelium but not in the airway mesenchymal cells. 20 In the current study, we find ␤ 8 expressed in cell processes in the subepithelial fibroblasts. The discrepancy between these two studies likely represents several methodological differences. In this study, we have used frozen tissues instead of paraffinembedded tissues, which is likely to have improved the sensitivity of detection. In addition, we have used a recently developed ␤ 8 -polyclonal antibody, which has been tested for staining specificity using frozen sections from mice deficient in all ␣ v integrins. 23 Using this new antibody, it is apparent that ␣ v ␤ 8 is more widely distributed than initially thought and is expressed in both epithelial and mesenchymal cells of the lung.
The majority of TGF-␤ in vivo is latent and therefore nonfunctional, and active TGF-␤ is difficult to detect in vivo, presumably because of its short half-life. 40 -42 Yet, we and others find evidence of widespread TGF-␤ signaling by most fetal airway epithelial and mesenchymal cells in tissue sections. 43 Thus, in vivo, fetal tracheal cells are likely to be exposed to activated TGF-␤ at low but sufficient levels to induce continuous signaling. Our in vitro data suggests that the integrin ␣ v ␤ 6 , expressed by epithelial cells, and ␣ v ␤ 8 , expressed by fibroblasts, play major roles in this local activation of TGF-␤.
There are several possible roles for integrin-mediated activation of TGF-␤ in fetal lung development. TGF-␤1 and TGF-␤3, respectively, have been shown to either inhibit or stimulate lung-branching morphogenesis, possibly reflecting distinct TGF-␤ isoform-specific spatiotemporal localization patterns. 6,44 -46 Thus, the integrins ␣ v ␤ 6 and ␣ v ␤ 8 could play a role in lung branching morphogenesis because both ␣ v ␤ 6 and ␣ v ␤ 8 mediate activation of TGF-␤1 and TGF-␤3 and have distinct spatiotemporal expression patterns. In addition, ␣ v ␤ 8 -dependent TGF-␤ activation regulates the fetal tracheal fibroblastic autocrine secretion of HGF, which has also been shown to influence lung epithelial morphogenesis. 36 Immunohistochemisty suggests that the integrin ␣ v ␤ 8 is expressed at high levels and the integrin ␤ 6 at low levels in the airway epithelium. However, airway epithelial cells appear normally and efficiently to support only ␣ v ␤ 6 -mediated TGF-␤ activation. This suggests that integrin ␣ v ␤ 6 -mediated activation is regulated by expression levels of ␣ v ␤ 6 , and ␣ v ␤ 8 -mediated activation of TGF-␤ is regulated by some other mechanism. Interestingly, airway fibroblasts express relatively low levels of ␣ v ␤ 8 yet efficiently support ␣ v ␤ 8 -mediated activation of TGF-␤. This demonstrates that surface expression of ␣ v ␤ 8 does not necessarily correlate with the magnitude of TGF-␤ activation, which is most likely attributable to the contribution of the metalloproteolytic co-factor MT1-MMP, a co-factor required for ␣ v ␤ 8 -mediated activation of TGF-␤ in lung carcinoma cells. 15 Indeed, we found that airway epithelial cells have reduced surface levels and activity of MT1-MMP compared to airway fibroblasts.
MT1-MMP plays a major role in pericellular proteolysis and has been shown to regulate cell migration, invasion, proliferation, and differentiation through diverse mechanisms. 34, 47 For instance, MT1-MMP has been shown to modify the platelet-derived growth factor signaling of vascular smooth muscle cells, which in turn regulates vessel wall architecture. 47 Here, our data suggests that induction of MT1-MMP activity may play a similar role in the regulation of TGF-␤ signaling through the regulation of the ␣ v ␤ 8 -dependent activation of TGF-␤.
In the adult airway, aberrant reactivation of the EMTU is likely to occur in airway remodeling in asthma and smoking-related airways disease, and amplification of TGF-␤ activation and metalloprotease activity are likely to be important in this reactivation. 4 In this regard, integrin ␣ v ␤ 8 -mediated activation of TGF-␤ could be a crucial determinant in aberrant reactivation of the EMTU because airway epithelial cells express high levels of ␣ v ␤ 8 and both MT1-MMP activity and the ability of ␣ v ␤ 8 to activate TGF-␤ can be markedly enhanced by PMA, a potent agonist of protein kinase C (PKC). 48 Oxidative stress has been shown to increase both PKC and MT1-MMP activity, providing a possible physiological link between environmental stress and ␣ v ␤ 8 -mediated activation of TGF-␤. 49, 50 Finally, increased integrin-mediated activation of TGF-␤ could result in delayed epithelial wound closure and stimulation of subepithelial fibroblastic extracellular matrix production, ultimately contributing to airway remodeling.
In summary, we have determined a novel pathway of autocrine integrin-dependent TGF-␤ activation within the EMTU of the lung, which ultimately regulates fibroblastepithelial interactions through the paracrine secretion of TGF-␤ of the epithelial mitogen HGF (Figure 7 ). These findings provoke further investigation into the cell-typespecific regulation of TGF-␤ activation in lung fibroblasts in diverse pulmonary pathological processes. 
